Enzo Biochem Ownership | Who Owns Enzo Biochem?

Enzo Biochem Ownership Summary

Enzo Biochem is owned by 6.03% institutional investors, 22.60% insiders, and 71.37% retail investors. Harbert fund advisors is the largest institutional shareholder, holding 9.91% of ENZ shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.27% of its assets in Enzo Biochem shares.

ENZ Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Enzo Biochem	6.03%	22.60%	71.37%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Diagnostics & Research Stocks	49.06%	8.59%	42.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Harbert fund advisors	5.18M	9.91%	$3.70M
Renaissance	2.37M	4.53%	$1.69M
Vanguard group	1.86M	3.56%	$1.33M
Blackrock	955.02K	1.86%	$1.04M
Blackrock funding, inc. /de	959.84K	1.84%	$685.61K
Geode capital management	367.09K	0.70%	$262.30K
Dimensional fund advisors lp	295.68K	0.57%	$211.13K
Rbf capital	250.36K	0.48%	$178.83K
Wittenberg investment management	187.54K	0.36%	$133.96K
Bridgeway capital management	177.20K	0.34%	$126.57K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Harbert fund advisors	5.18M	1.92%	$3.70M
Lepercq multi-asset fund	123.00K	0.06%	$87.86K
Lepercq de neuflize asset management	123.00K	0.06%	$87.86K
Wittenberg investment management	187.54K	0.05%	$133.96K
Nierenberg investment management company	88.56K	0.04%	$63.26K
Tls advisors	13.62K	0.02%	$10.00K
Kempner capital management	25.48K	0.01%	$18.00K
Rbf capital	250.36K	0.01%	$178.83K
Bbr partners	100.00K	0.01%	$71.43K
Shulman demeo asset management	15.49K	0.00%	$11.06K

Top Buyers

Holder	Shares	% Assets	Change
Lepercq multi-asset fund	123.00K	0.06%	123.00K
Lepercq de neuflize asset management	123.00K	0.06%	123.00K
Wittenberg investment management	187.54K	0.05%	70.40K
Engineers gate manager lp	52.28K	0.00%	52.28K
Virtu financial	48.34K	0.00%	48.34K

Top Sellers

Holder	Shares	% Assets	Change
Tang capital management	-	-	-1.26M
Renaissance	2.37M	0.00%	-159.99K
Fny investment advisers	-	-	-20.00K
Assenagon asset management	-	-	-19.77K
Pfg investments	-	-	-18.66K

New Positions

Holder	Shares	% Assets	Change	Value
Lepercq multi-asset fund	123.00K	0.06%	123.00K	$87.86K
Lepercq de neuflize asset management	123.00K	0.06%	123.00K	$87.86K
Engineers gate manager lp	52.28K	0.00%	52.28K	$37.34K
Virtu financial	48.34K	0.00%	48.34K	$35.00K
Citadel advisors	34.00K	-	34.00K	$37.06K

Sold Out

Holder	Change
Newedge advisors	-10.00
Bnp paribas	-79.00
Clear point advisors	-120.00
Advisor group	-120.00
Simplex trading	-2.77K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	11	-75.00%	3,150,870	-75.09%	6	1.03%	5	-61.54%	2	-71.43%
Sep 30, 2024	44	12.82%	12,649,378	2.18%	24	4.14%	13	-	7	-22.22%
Jun 30, 2024	39	-2.50%	12,380,058	-10.44%	24	3.23%	13	44.44%	9	-18.18%
Mar 31, 2024	40	-13.04%	13,822,593	-15.48%	27	2.61%	9	-50.00%	11	22.22%
Dec 31, 2023	46	9.52%	16,355,143	-1.36%	32	2.97%	18	50.00%	9	-10.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.19M	2.27%	-
Vanguard Total Stock Mkt Idx Inv	1.19M	2.27%	-
Vanguard Institutional Extnd Mkt Idx Tr	618.88K	1.18%	-
Fidelity Extended Market Index	208.72K	0.40%	-1.33K
Bridgeway Ultra-Small Company Market	175.20K	0.34%	-
iShares Micro-Cap ETF	99.11K	0.19%	-
Dimensional US Targeted Value ETF	81.91K	0.16%	-
BlackRock Extended Equity Market K	78.20K	0.15%	-33.00
Extended Equity Market Fund K	77.37K	0.15%	237.00
Fidelity Total Market Index	55.21K	0.11%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 10, 2023	Wolf James G.	-	Buy	$6.45K
Feb 13, 2023	Wolf James G.	-	Buy	$6.45K
Feb 13, 2023	Wolf James G.	-	Buy	$1.88K
Feb 13, 2023	Wolf James G.	-	Sell	$1.62K
Feb 13, 2023	Wolf James G.	-	Buy	$6.42K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-

ENZ Ownership FAQ

Who Owns Enzo Biochem?

Enzo Biochem shareholders are primarily institutional investors at 6.03%, followed by 22.60% insiders and 71.37% retail investors. The average institutional ownership in Enzo Biochem's industry, Diagnostics & Research Stocks, is 49.06%, which Enzo Biochem falls below.

Who owns the most shares of Enzo Biochem?

Enzo Biochem’s largest shareholders are Harbert fund advisors (5.18M shares, 9.91%), Renaissance (2.37M shares, 4.53%), and Vanguard group (1.86M shares, 3.56%). Together, they hold 18.00% of Enzo Biochem’s total shares outstanding.

Does Blackrock own Enzo Biochem?

Yes, BlackRock owns 1.86% of Enzo Biochem, totaling 955.02K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.04M$. In the last quarter, BlackRock increased its holdings by 1.03K shares, a 0.11% change.

Who is Enzo Biochem’s biggest shareholder by percentage of total assets invested?

Harbert fund advisors is Enzo Biochem’s biggest shareholder by percentage of total assets invested, with 1.92% of its assets in 5.18M Enzo Biochem shares, valued at 3.7M$.

Who is the top mutual fund holder of Enzo Biochem shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Enzo Biochem shares, with 2.27% of its total shares outstanding invested in 1.19M Enzo Biochem shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools